Probaclac E
Probaclac E, licence 80069647: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Les laboratoires Nicar inc.
- NPN or DIN-HM
- 80069647
- Status
- Inactive licence
- Licence date
- 24 May 2016
- Revision date
- 22 December 2020
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium breve Source : Bifidobacterium breve A055 | 300.0 % | Not calculated |
| Bifidobacterium breve Source : Cellule entière | 300.0 % | Not calculated |
| Bifidobacterium breve Source : Bifidobacterium breve A055 | 338.0 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : Cellule entière | 338.0 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : Bifidobacterium longum subsp. longum A027 | 300.0 % | Not calculated |
| Bifidobacterium longum subsp. longum Source : Cellule entière | 300.0 % | Not calculated |
| Bifidobacterium longum subsp. longum Source : Bifidobacterium longum subsp. longum A027 | 113.0 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : Cellule entière | 113.0 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Sucrose, Acide ascorbique, Cellulose microcristalline, Sorbitol, Maltodextrine, Anthocyanines, Stéarate de magnésium, Saveur de raisin, Betterave rouge, Inuline, Amidon de maïs, Acide citrique, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants et Adolescents | minimum: 3.0 Année(s) | minimum: 1.0 Comprimé | 2.0 Tous les jours |
Uses authorised in Canada
Contribue à soutenir la santé intestinale/gastrointestinal.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Si vous souffrez de fièvre, de vomissements, de diarrhée sanglante ou de douleurs abdominales intenses, consulter un praticien de soins de santé avant d'en faire l'usage. Si des symptômes de troubles digestifs (p. ex. diarrhée) se manifestent, s'aggravent et/ou persistent au-delà de 3 jours, cesser l'utilisation et consulter in praticien de soins de santé. Ce produit ne contient pas de gluten, soya, protéines laitières, arachides, noix, sésame, oeufs, poisson, crustacés, blé et sulfites.
- Contre-indications
Si vous souffrez d'un déficit immunitaire (p. ex. sida, lymphome, patients subissant un traitement prolongé aux corticostéroïdes), ne pas utiliser ce produit.
Source
Official Health Canada record, licence 80069647
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.